Asthma trials in South Korea

In South Korea 13 Also abroad 500

13 trials · From ClinicalTrials.gov, checked 11 November 2026. Ask the study team whether a trial fits you.

Phase 3Taking people
A Study to Investigate the Efficacy and Safety of Tezepelumab Compared With Placebo in Children 5 to < 12 Years Old With Severe Asthma
Where
Seongnam-si, Seoul
Age
5 years to 11 years
People
231 worldwide
Run by
AstraZeneca
See details and how to joinNCT06023589
Phase 3Taking people
A Study to Investigate GB-0895 Adjunctive Therapy in Adults and Adolescents With Severe Uncontrolled Asthma (SOLAIRIA-1)
Where
Anyang-si, Busan, Seoul
Age
12 years to 80 years
People
786 worldwide
Run by
Generate Biomedicines
See details and how to joinNCT07276724 · EU 2025-521950-41-00
Phase 3Taking people
Roll-over Study for Participants Who Have Completed a Previous Clinical Study With Benralizumab (Fasenra) and Benefit From Continued Treatment
Where
Incheon
Age
6 years and over
People
230 worldwide
Run by
AstraZeneca
See details and how to joinNCT07444567
Phase 2Taking people
A Study to Learn About the Study Medicine Called PF-07275315 in People With Moderate-To-Severe Asthma
Where
Daegu, Jeonju, Seoul
Age
18 years to 75 years
People
252 worldwide
Run by
Pfizer
See details and how to joinNCT06977581 · EU 2024-517866-40-00
Phase 2Taking people
Dose Range Finding Study to Assess Efficacy and Safety of Tozorakimab in Adults With Uncontrolled Asthma on Medium-to-High Dose Inhaled Corticosteroids
Where
Cheongju-si, Daegu, Seoul
Age
18 years to 75 years
People
540 worldwide
Run by
AstraZeneca
See details and how to joinNCT06932263 · EU 2024-519116-14-00
Phase 2Taking people
A Study of KT-621 Administered Orally to Adult Participants With Moderate to Severe Eosinophilic Asthma
Where
Gyeonggi-do, Seoul
Age
18 years to 75 years
People
264 worldwide
Run by
Kymera Therapeutics, Inc.
See details and how to joinNCT07323654
No phaseTaking people
BREZTRI REGULATORY POST MARKETING SURVEILLANCE IN KOREA
Where
Chuncheon, Daegu, Goyang-si, Gwangmyeong, Jinju, Seongnam-si, Seoul, Wŏnju
People
600
Run by
AstraZeneca
See details and how to joinNCT07570394
Phase 2Enrolling by invitation
Long-term Safety and Efficacy Evaluation of Lunsekimig (SAR443765) in Adult Participants With Asthma
Where
Seoul
Age
18 years and over
People
900 worldwide
Run by
Sanofi
See details and how to joinNCT06609239 · EU 2025-522896-27-00
No phaseTaking people
Quantitative Chest CT and Multi-Omics to Distinguish Asthma From COPD and Predict Treatment Response
Where
Seoul
Age
19 years and over
People
200
Run by
Korea University Guro Hospital
See details and how to joinNCT07602192
Phase 3Taking people
Depemokimab Asthma Imaging and Bronchoscopy Sub-Study
Where
Jeonju, Seoul
Age
18 years and over
People
150 worldwide
Run by
GlaxoSmithKline
See details and how to joinNCT06979323 · EU 2024-519976-19-00
Phase 3Taking people
Study to Evaluate the Efficacy and Safety of DW1807 in Perennial Allergic Rhinitis Patients With Asthma
Where
Seoul
Age
19 years and over
People
274
Run by
Daewon Pharmaceutical Co., Ltd.
See details and how to joinNCT07168473
No phaseTaking people
Controls for Respiratory Diseases
Where
Seoul
Age
19 years to 90 years
People
1,572
Run by
Seoul National University Hospital
See details and how to joinNCT03120481
No phaseTaking people
Seoul National University Airway Registry
Where
Seongnam-si, Seoul
Age
20 years to 90 years
People
800
Run by
Seoul National University Hospital
See details and how to joinNCT02527486